A detailed history of Barrow Hanley Mewhinney & Strauss LLC transactions in Sanofi stock. As of the latest transaction made, Barrow Hanley Mewhinney & Strauss LLC holds 7,837,829 shares of SNY stock, worth $375 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares
7,837,829
Previous 5,943,547 31.87%
Holding current value
$375 Million
Previous $288 Million 56.71%
% of portfolio
1.56%
Previous 1.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$48.54 - $58.53 $91.9 Million - $111 Million
1,894,282 Added 31.87%
7,837,829 $452 Million
Q2 2024

Aug 13, 2024

BUY
$45.39 - $50.36 $144 Million - $159 Million
3,164,092 Added 113.84%
5,943,547 $288 Million
Q1 2024

May 13, 2024

BUY
$45.75 - $52.48 $127 Million - $146 Million
2,779,455 New
2,779,455 $135 Million
Q2 2022

Aug 11, 2022

SELL
$48.99 - $57.46 $2.92 Million - $3.43 Million
-59,678 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$48.48 - $53.65 $514,857 - $569,763
-10,620 Reduced 15.11%
59,678 $3.06 Million
Q3 2021

Nov 12, 2021

SELL
$47.89 - $53.12 $83,424 - $92,535
-1,742 Reduced 2.42%
70,298 $3.39 Million
Q2 2021

Aug 12, 2021

SELL
$49.36 - $54.25 $216,591 - $238,049
-4,388 Reduced 5.74%
72,040 $3.79 Million
Q4 2020

Feb 11, 2021

SELL
$45.3 - $51.62 $46,885 - $53,426
-1,035 Reduced 1.34%
76,428 $3.71 Million
Q3 2020

Nov 12, 2020

SELL
$49.47 - $53.77 $1.08 Million - $1.18 Million
-21,859 Reduced 22.01%
77,463 $3.89 Million
Q2 2020

Aug 12, 2020

SELL
$42.91 - $52.5 $22 Million - $26.9 Million
-512,972 Reduced 83.78%
99,322 $5.07 Million
Q1 2020

May 15, 2020

SELL
$38.02 - $51.66 $17.9 Million - $24.3 Million
-471,278 Reduced 43.49%
612,294 $26.8 Million
Q4 2019

Feb 12, 2020

SELL
$44.25 - $50.86 $414 Million - $476 Million
-9,354,695 Reduced 89.62%
1,083,572 $54.4 Million
Q3 2019

Nov 14, 2019

SELL
$40.34 - $46.64 $120 Million - $138 Million
-2,966,281 Reduced 22.13%
10,438,267 $484 Million
Q2 2019

Aug 13, 2019

SELL
$40.43 - $44.3 $371 Million - $406 Million
-9,172,732 Reduced 40.63%
13,404,548 $580 Million
Q1 2019

May 14, 2019

BUY
$40.83 - $45.43 $4.5 Million - $5.01 Million
110,258 Added 0.49%
22,577,280 $1 Billion
Q4 2018

Feb 13, 2019

BUY
$41.48 - $45.59 $84.6 Million - $93 Million
2,039,820 Added 9.99%
22,467,022 $975 Million
Q3 2018

Nov 13, 2018

BUY
$40.0 - $44.84 $38.2 Million - $42.8 Million
954,977 Added 4.9%
20,427,202 $912 Million
Q2 2018

Aug 14, 2018

SELL
$37.63 - $41.22 $81 Million - $88.7 Million
-2,152,785 Reduced 9.96%
19,472,225 $779 Million
Q1 2018

May 14, 2018

SELL
$38.98 - $45.76 $29.4 Million - $34.5 Million
-753,807 Reduced 3.37%
21,625,010 $867 Million
Q4 2017

Feb 09, 2018

SELL
$42.86 - $50.61 $68.1 Million - $80.4 Million
-1,587,732 Reduced 6.62%
22,378,817 $962 Million
Q3 2017

Nov 13, 2017

BUY
$47.04 - $50.34 $1.13 Billion - $1.21 Billion
23,966,549
23,966,549 $1.19 Billion

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Barrow Hanley Mewhinney & Strauss LLC Portfolio

Follow Barrow Hanley Mewhinney & Strauss LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barrow Hanley Mewhinney & Strauss LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barrow Hanley Mewhinney & Strauss LLC with notifications on news.